BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4939823)

  • 1. Presence of both cell-mediated immunity and serum-blocking factors in rat renal allografts "enhanced" by passive immunization.
    Stuart FP; Fitch FW; Rowley DA; Hellström I; Biesecker JL; Hellström KE
    Transplantation; 1971 Oct; 12(4):331-3. PubMed ID: 4939823
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose response studies in passive enhancement on rat renal allografts.
    Fabre JW; Morris PJ
    Transplantation; 1973 Apr; 15(4):397-403. PubMed ID: 4575927
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive enhancement of homozygous renal allografts in the rat.
    Fabre JW; Morris PJ
    Transplantation; 1974 Nov; 18(5):429-35. PubMed ID: 4610921
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal transplantation between histoincompatible rats.
    Ippolito RJ; Mahoney RJ; Murray IM
    Transplantation; 1974 Jan; 17(1):89-96. PubMed ID: 4271944
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with passive enhancement of renal allografts in A (DA x Lewis)F 1 to Lewis Strain combination.
    Fabre JW; Morris PJ
    Transplantation; 1972 Jun; 13(6):604-9. PubMed ID: 4556072
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive antibody delays development of cell-mediated immunity in rats receiving renal allografts.
    Biesecker JL; Fitch FW; Rowley DA; Stuart FP
    Transplant Proc; 1973 Mar; 5(1):667-9. PubMed ID: 4572125
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular and humoral immunity after allogeneic transplantation in the rat. 3. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation.
    Biesecker JL; Fitch FW; Rowley DA; Stuart FP
    Transplantation; 1973 Nov; 16(5):432-40. PubMed ID: 4584953
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors.
    Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP
    Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952
    [No Abstract]   [Full Text] [Related]  

  • 9. Passive enhancement of rat renal allografts with only partial cover of the incompatible Ag-B specificities.
    Fabre JW; Morris PJ
    Transplantation; 1974 Nov; 18(5):436-42. PubMed ID: 4610922
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated reactivity and serum blocking activity in tolerant rats. Studies on ten rats operationally tolerant to skin allografts using several independent assays.
    Wright PW; Bernstein ID; Hamilton B; Gluckman JC; HELLSTROM KE
    Transplantation; 1974 Jul; 18(1):46-55. PubMed ID: 4152086
    [No Abstract]   [Full Text] [Related]  

  • 11. Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation.
    Garovoy MR; Franco V; Zschaeck D; Carpenter CB; Strom TB; Merrill JP
    Lancet; 1973 Mar; 1(7803):573-6. PubMed ID: 4120643
    [No Abstract]   [Full Text] [Related]  

  • 12. LD-SD interaction in vivo and the allograft reaction.
    van Rood JJ
    Transplant Proc; 1973 Dec; 5(4):1747-50. PubMed ID: 4272829
    [No Abstract]   [Full Text] [Related]  

  • 13. Presensitization and clinical kidney transplantation. II. Correlative studies of humoral and cellular immunity and clinical course.
    Myburgh JA; Maier G; Smit JA; Shapiro M; Meyers AM; Rabkin R; Van Blerk PJ; Jersky J
    Transplantation; 1974 Sep; 18(3):213-22. PubMed ID: 4607999
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 15. Passive enhancement of kidney allografts: potentiation with antithymocyte serum.
    Batchelor JR; Fabre J; Morris PJ
    Transplantation; 1972 Jun; 13(6):610-3. PubMed ID: 4556073
    [No Abstract]   [Full Text] [Related]  

  • 16. The early effects of alloantibody and complement on rat kidney allografts.
    French ME
    Transplantation; 1972 May; 13(5):447-51. PubMed ID: 4557794
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunologic status of rats with long-surviving (enhanced) kidney allografts.
    Mullen Y; Takasugi M; Hildemann WH
    Transplant Proc; 1973 Mar; 5(1):611-6. PubMed ID: 4572120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is permanent survival of kidney allograft receivers in weak histo-incompatible combinations dependent on enhancement?].
    Kanda M; Oehr P; Choi SK; Kim WI; Lie TS
    Chir Forum Exp Klin Forsch; 1977 Apr; ():264-8. PubMed ID: 376242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatched HL-A haplotypes with antigens HL-A1, 3, and 11 associated with excellent renal allograft function.
    Braun WE; Straffon RA; Nakamoto S; Popowniak KL; Gifford RW; Kuruvila C; Zachary AA
    Transplantation; 1973 Jan; 15(1):86-91. PubMed ID: 4575924
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological enhancement of rat kidney grafts.
    French ME; Batchelor JR
    Lancet; 1969 Nov; 2(7630):1103-6. PubMed ID: 4186995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.